Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

Hopital Universitaire Erasme, Brussels

Instituto Portugues de Oncologia de Francisco Gentil, Lisbon

National Institute of Neurosurgery, Budapest

Rigshospitalet, Copenhagen

Universita Degli Studi di Torino, Torino

CHU de la Timone, Marseille

Centre Regional Francois Baclesse, Caen

C.H.R. de Nimes - Hopital Caremeau, Nîmes

Institut Bergonie, Bordeaux

Azienda Ospedaliera di Padova, Padova (Padua)

CRLCC Nantes - Atlantique, Nantes-Saint Herblain

CHU de Nancy - Hopital Neurologique, Nancy

Hopital Louis Pasteur, Colmar

Centre Leon Berard, Lyon

CHU Pitie-Salpetriere, Paris

Centre Hospitalier Universitaire de Bicetre, Le Kremlin-Bicêtre

Kaiser Franz Josef Hospital, Vienna (Wien)

Helsinki University Central Hospital, Helsinki

Turku University Central Hospital, Turku

Hopital Pasteur, Nice

Centre Antoine Lacassagne, Nice

Institut Gustave Roussy, Villejuif

Universitaetsklinikum Benjamin Franklin, Berlin

Neurologische Klinik der Henriettenstiftung, Hanover

Universitaetsklinikum Tuebingen, Tübingen

Academisch Ziekenhuis der Vrije Universiteit, Amsterdam

Antoni van Leeuwenhoekhuis, Amsterdam

Academisch Ziekenhuis Groningen, Groningen

Academisch Ziekenhuis Maastricht, Maastricht

St. Radboud University Hospital, Nijmegen

Rotterdam Cancer Institute, Rotterdam

St. Elisabeth Ziekenhuis, Tilburg

Dr. Bernard Verbeeten Instituut, Tilburg

Academisch Ziekenhuis Utrecht, Utrecht

Umea Universitet, Umeå

Western General Hospital, Edinburgh

Beatson Oncology Centre, Glasgow